2 studies found for:    16236737 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: 5-Fu/epirubicin/CTX following Docetaxel;   Drug: Docetaxel/capecitabine followed by XEC
2 Active, not recruiting Trastuzumab in Treating Women With Primary Breast Cancer
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Procedure: adjuvant therapy

Indicates status has not been verified in more than two years